You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sustained remission

Showing 1 - 25 of 5,529
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Synovial Tissue and Blood Signature of Rheumatoid Arthritis

Active, not recruiting
  • Rheumatoid Arthritis
  • Evaluation of subclinical inflammation
  • Brescia, Lombardia, Italy
  • +2 more
Mar 2, 2023

Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis

Recruiting
  • Rheumatoid Arthritis
  • Tapering and/or discontinuation of treatment based on AI-guidance
  • +3 more
  • Rome, Italy
  • +3 more
Jul 20, 2023

Opioid Use Disorder, Severe, in Sustained Remission, Opioid Use Disorder, Severe, in Early Remission, MDD Trial in Charleston

Recruiting
  • Opioid Use Disorder, Severe, in Sustained Remission
  • +2 more
  • Ketamine-assisted psychotherapy
  • Charleston, South Carolina
    Medical University of South Carolina Centerspace
Feb 23, 2022

Crohn Disease, Pediatric Crohns Disease Trial in Worldwide (Azithromycin, Metronidazole, Standard of Care)

Recruiting
  • Crohn Disease
  • Pediatric Crohns Disease
  • San Francisco, California
  • +4 more
Apr 19, 2022

Crohn Disease Trial in Worldwide (Infliximab, Placebo)

Completed
  • Crohn Disease
  • Aarhus, Aarhus C, Denmark
  • +12 more
Mar 9, 2022

Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (eltrombopag)

Completed
  • Immune Thrombocytopenic Purpura (ITP)
  • Nyack, New York
  • +31 more
Nov 3, 2022

People With Multiple Myeloma in MRD-Negative Remission

Recruiting
  • Plasma Cell Myeloma
  • Cessation of continuous matinenace therapy
  • Basking Ridge, New Jersey
  • +6 more
Mar 30, 2022

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Active Lupus Nephritis at Sohag University Hospital

Active, not recruiting
  • We Aim to Examine the Predictors of Sustained Complete Renal Remission in Patients With Lupus Nephritis at Sohag University Hospital
  • Sohag, Egypt
    Sohag University
Feb 14, 2021

ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

Recruiting
  • ANCA-associated Vasculitis
  • Maintenance Therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 20, 2023

Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Discontinuation of maintenance treatment
  • Cork, Ireland
    Cork University Hospital
May 10, 2023

ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)

Recruiting
  • ANCA Associated Vasculitis
  • Beijing, China
    Peking Union Medical College Hospital
Jul 19, 2023

Psoriatic Arthritis Trial in Norway (Imaging informed treat-to-target, Conventional treat-to-target)

Recruiting
  • Psoriatic Arthritis
  • Imaging informed treat-to-target
  • Conventional treat-to-target
  • Bergen, Norway
  • +11 more
Nov 23, 2022

Chronyc Myeloid Leukemia Trial in Italy, Netherlands (Imatinib, Nilotinib)

Active, not recruiting
  • Chronyc Myeloid Leukemia
  • Alessandria, Italy
  • +81 more
Jan 4, 2022

Bullous Pemphigoid Trial in Worldwide (dupilumab, Matching Placebo, Oral corticosteroids (OCS))

Recruiting
  • Bullous Pemphigoid
  • Scottsdale, Arizona
  • +50 more
Jan 13, 2023

Axial Spondyloarthrithis, Ankylosing Spondylitis Trial in Worldwide (Certolizumab Pegol, Placebo)

Completed
Has Results
  • Axial Spondyloarthrithis
  • Ankylosing Spondylitis
  • Certolizumab Pegol
  • Placebo
  • Glendale, Arizona
  • +107 more
Nov 26, 2020

Giant Cell Arteritis (GCA) Trial in Worldwide (Upadacitinib, Corticosteroid (CS), Placebo)

Recruiting
  • Giant Cell Arteritis (GCA)
  • Huntsville, Alabama
  • +173 more
Aug 23, 2022

Crohn's Disease Trial in Worldwide (Modified Exclusive Enteral Nutrition, Crohn's Disease Exclusion Diet, Partial Enteral

Completed
  • Crohn's Disease
  • Modified Exclusive Enteral Nutrition
  • +3 more
  • Edmonton, Canada
  • +6 more
May 29, 2022

Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

Active, not recruiting
  • Colitis,Ulcerative
  • Discontinuation of anti-TNF treatment
  • Continuation of anti-TNF treatment
  • Alesund, Norway
  • +18 more
Jul 13, 2022

Nephrotic Syndrome Trial in Ranica (Blood sampling)

Recruiting
  • Nephrotic Syndrome
  • Blood sampling
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Jan 25, 2023

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis

Recruiting
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Phenotyping of synovial immune and stromal cells
  • Rome, Italy
  • +1 more
Mar 2, 2023

COVID-19 Trial in Beijing, Shenzhen (STI-1558, STI-1558 )

Not yet recruiting
  • COVID-19
  • Beijing, China
  • +1 more
Feb 5, 2023

Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)

Not yet recruiting
  • Polymyalgia Rheumatica
  • Secukinumab 300 mg
  • +2 more
  • (no location specified)
Mar 6, 2023

Bullous Pemphigoid Trial (efgartigimod PH20 SC, Prednisone)

Not yet recruiting
  • Bullous Pemphigoid
  • (no location specified)
Dec 27, 2022

Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)

Not yet recruiting
  • Ulcerative Colitis
  • IV MK-7240
  • +3 more
  • (no location specified)
Sep 27, 2023